Bio-Connect
Western Blot analysis of adrenal pheochromocytoma tissue,Jurkat and A549 cell using VWA5A Polyclonal Antibody at dilution of 1:275
Western Blot analysis of adrenal pheochromocytoma tissue,Jurkat and A549 cell using VWA5A Polyclonal Antibody at dilution of 1:275
Western Blot analysis of adrenal pheochromocytoma tissue,Jurkat and A549 cell using VWA5A Polyclonal Antibody at dilution of 1:275

VWA5A Polyclonal Antibody

Research Use Only
E-AB-14788
Elabscience
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Elabscience
  • Product Name
    VWA5A Polyclonal Antibody
  • Delivery Days Customer
    12
  • Applications Supplier
    ELISA WB IHC
  • Certification
    Research Use Only
  • Concentration
    0.5mg/ml
  • Scientific Description
    VWA5A (von Willebrand factor A domain containing 5A), also known as BCSC-1 (breast cancer suppressor candidate 1) or LOH11CR2A (loss of heterozygosity 11 chromosomal region 2 gene A protein), is a 786 amino acid protein containing one VIT domain and one VWFA domain. VWA5A is expressed at low levels in various tissues, with no expression found in 80% of tumor cell lines. Likely acting as a tumor suppressor gene, deletion of VWA5A leads to loss of heterozygosity (LOH) in breast and ovarian tumors, and may have an important role as a potential gene therapy target. Abnormal expression of VWA5A may lead to an increase in adhesion of CNE-2L2 cells associated with an increase in expression of E-cadherin, alpha-catenin, and p53, resulting in a decrease of malignant activity in cells with ectopic expression of VWA5A.
  • UNSPSC
    12352203